Selected Publications

• EHBP1 suppresses liver fibrosis in metabolic dysfunction-associated steatohepatitis. Fanglin Ma, Miriam Longo, Marica Meroni, Dipankar Bhattacharya, Erika Paolini, Shama Mughal, Syed Hussain, Sumit Kumar Anand, Neha Gupta, Yiwei Zhu, Amaia Navarro-Corcuera, Kenneth Li, Satya Prakash, Bruno Cogliati, Shuang Wang, Xin Huang, Xiaobo Wang, Arif Yurdagul, Oren Rom, Liheng Wang, Susan K. Fried, Paola Dongiovanni, Scott L. Friedman, Bishuang Cai. Cell Metabolism
• Addressing the High and Rising Global Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH): From the Growing Prevalence to Payors' Perspective. Zobair M. Younossi, Homie Razavi, Michael Sherman, Alina M. Allen, Quentin M. Anstee, Kenneth Cusi, Scott L. Friedman, Eric Lawitz, Jeffrey V. Lazarus, Detlef Schuppan, Manuel Romero-Gómez, Jörn M. Schattenberg, Miriam B. Vos, Vincent Wai Sun Wong, Vlad Ratziu, Marcus Hompesch, Arun J. Sanyal, Rohit Loomba. Alimentary Pharmacology and Therapeutics
• Can we talk? The cryptic communications of hepatic stellate cells in lipid metabolism. Scott L. Friedman. Cell Metabolism